DILTAN 90 SR Cardocaps Price

Overview

Welcome to Dwaey, specifically on DILTAN 90 SR Cardocaps Capsules (Hard Gelatin) page.
This medicine contains an important and useful components, as it consists of Diltiazem HCl.
DILTAN 90 SR Cardocaps is available in the market in concentration 90mg/Capsule and in the form of Capsules (Hard Gelatin).

MEPHA LTD. is the producer of DILTAN 90 SR Cardocaps and it is imported from SWITZERLAND, The most popular alternatives of DILTAN 90 SR Cardocaps are listed downward .

Mode Of Action

Diltiazem relaxes coronary vascular smooth muscles by inhibiting influx of calcium ions during depolarisation of the vascular smooth muscles and myocardium. It increases myocardial O2 delivery in patients with vasospastic angina and inhibits cardiac conduction, particularly at the SA and AV nodes.

Indication

• Supraventricular tachycardia
• Hypertension
• Angina
• Atrial fibrillation
• Arrhythmias
• Atrial flutter

Precaution

Elderly. Hepatic or renal impairment; impaired left ventricular function; prolonged AV periods; DM; hypotension. Avoid abrupt withdrawal and long-term use. Patients with sick-sinus syndrome, preexisting AV block, bradycardia and those taking beta-blockers or digitalis are at risk of developing AV block, bradycardia, asystole or sinus arrest. Lactation: Drug enters breast milk; because of risk for serious adverse reactions in nursing infants from diltiazem, a decision should be made whether to discontinue nursing or to discontinue the drug, taking into account the importance of the drug to the mother

Side Effects

• >10% Edema (2-15%)
• Headache (5-12%) 1-10% Dizziness (3-10%)
• AV block (2-8%)
• Peripheral edema (2-8%)
• Bradyarrhythmia (2-6%)
• Headache (1-5%)
• Hypotension (2-4%)
• Nausea (3%)
• Vomiting (2%)
• Vasodilation (2-3%)
• Extrasystoles (2%)
• Flushing (1-2%)
• Drug-induced gingival hyperplasia (<2%)
• Myalgia (2%)
• Diarrhea (1-2%)
• Constipation (2-4%)
• Bronchitis (1-4%)
• Sinus congestion (1-2%)
• Dyspnea (1-6%)
• Congestion (1-2%) < 1% Increased Alkaline phosphatase as well as ALT and AST
• CHF
• Thrombocytopenia
• Toxic epidermal necrolysis
• Hemolytic anemia
• Photosensitivity
• Extrapyramidal symptoms
• Syncope

Contra indication

Sick-sinus syndrome; 2nd or 3rd ° AV block; porphyria. Severe congestive cardiac failure; marked bradycardia. Pregnancy and lactation.

Pregnancy and lactation

Pregnancy category: C

Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks